Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer
作者
Stephanie L. Wethington,Payal Deepak Shah,Lainie P. Martin,Janos Laszlo Tanyi,Nawar Latif,Mark Aloysuis Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Jane Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah Kay Armstrong,Stephanie L. Gaillard,Robert Lawrence Giuntoli,Fiona A. Simpkins